Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Bright Minds Biosciences | CSE | Healthcare | Biotechnology & Medical Research | $323.04M | -236.8x | -3.45 | $45.86 | -1.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
ME Therapeutics Holdings | CSE | Healthcare | Biotechnology & Medical Research | $261.89M | -158.1x | -2.44 | $10 | 25% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
NervGen Pharma | TSXV | Healthcare | Biotechnology & Medical Research | $209.79M | -9.3x | -1.58 | $2.97 | -3.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Fennec Pharma | Toronto | Healthcare | Biotechnology & Medical Research | $205.97M | -325x | -3.44 | $7.45 | -10.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Cybin | CBOE Canada | Healthcare | Biotechnology & Medical Research | $170.18M | -2.3x | -0.03 | $8.07 | -5.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
ZEN Graphene | TSXV | Healthcare | Biotechnology & Medical Research | $154.33M | -13.7x | -1.72 | $1.48 | -3.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Eupraxia Pharmaceuticals | Toronto | Healthcare | Biotechnology & Medical Research | $148.77M | -4.2x | -0.12 | $4.15 | -6.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Satellos Bioscience | Toronto | Healthcare | Biotechnology & Medical Research | $107.79M | -3.3x | 0.12 | $0.65 | -1.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Cardiol Therapeutics | Toronto | Healthcare | Biotechnology & Medical Research | $98.30M | -2.7x | 0.15 | $1.19 | -9.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Medicenna | Toronto | Healthcare | Biotechnology & Medical Research | $70.39M | -3x | 0.04 | $0.90 | -3.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Sharp Therapeutics | TSXV | Healthcare | Biotechnology & Medical Research | $60.67M | -0x | $2.15 | -5.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Oncolytics Biotech | Toronto | Healthcare | Biotechnology & Medical Research | $60.50M | -2.2x | 1.86 | $0.70 | -1.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Zyus Life Sciences | TSXV | Healthcare | Biotechnology & Medical Research | $58M | -1.7x | 0.43 | $0.78 | 1.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Microbix Biosystems Inc. | Toronto | Healthcare | Biotechnology & Medical Research | $57.99M | 41x | -0.63 | $0.41 | -2.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Defence Therapeutics | CSE | Healthcare | Biotechnology & Medical Research | $53.08M | -15.5x | -0.18 | $0.97 | -6.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Defence Therapeutics | CSE | Healthcare | Biotechnology & Medical Research | $53.08M | -15.5x | -0.18 | $0.97 | -6.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
NurExone Biologic | TSXV | Healthcare | Biotechnology & Medical Research | $49.67M | -6.1x | -0.38 | $0.67 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
MustGrow Biologics | TSXV | Healthcare | Biotechnology & Medical Research | $48.03M | -372.5x | -2.06 | $0.93 | -1.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
KDA Group | TSXV | Healthcare | Biotechnology & Medical Research | $46.17M | -5.6x | 0.04 | $0.25 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Helix BioPharma Corp. | Toronto | Healthcare | Biotechnology & Medical Research | $41.89M | -4x | 0.09 | $0.79 | 0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Sona Nanotech | CSE | Healthcare | Biotechnology & Medical Research | $29.82M | -9.6x | -1 | $0.26 | -1.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Thiogenesis Therapeutics | TSXV | Healthcare | Biotechnology & Medical Research | $29.58M | -7x | 4.4 | $0.65 | 6.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Quantum BioPharma | CSE | Healthcare | Biotechnology & Medical Research | $27.06M | -0.6x | -0.02 | $10 | -11.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Avicanna | Toronto | Healthcare | Biotechnology & Medical Research | $23.15M | -4.6x | -0.06 | $0.21 | -16% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Briacell Therapeutics | Toronto | Healthcare | Biotechnology & Medical Research | $20.55M | -0.6x | -0.03 | $5.54 | 12.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
BioMark Diagnostics Inc | CSE | Healthcare | Biotechnology & Medical Research | $19.88M | -73.5x | -0.14 | $0.26 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Pharmala Biotech Holdings | CSE | Healthcare | Biotechnology & Medical Research | $17.59M | $0.17 | 3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||||
Numinus Wellness Inc | Toronto | Healthcare | Biotechnology & Medical Research | $16.12M | -0.5x | -0.01 | $0.05 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Sirona Biochem Corp | TSXV | Healthcare | Biotechnology & Medical Research | $15.82M | -7.2x | 0.42 | $0.06 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Hemostemix Inc | TSXV | Healthcare | Biotechnology & Medical Research | $15.22M | -3.6x | -0.18 | $0.10 | 10.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
COSCIENS Biopharma | Toronto | Healthcare | Biotechnology & Medical Research | $14.13M | -0.2x | 0.02 | $3.76 | -2.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Rakovina Therapeutics | TSXV | Healthcare | Biotechnology & Medical Research | $13.38M | -2.2x | 0.34 | $0.10 | -9.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Biovaxys Technology | CSE | Healthcare | Biotechnology & Medical Research | $13.12M | -1.8x | -0.05 | $0.05 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Resverlogix Corp. | Toronto | Healthcare | Biotechnology & Medical Research | $12.74M | -0.9x | -0.06 | $0.05 | 12.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Glow Lifetech | CSE | Healthcare | Biotechnology & Medical Research | $10.19M | -3.1x | -0.18 | $0.06 | -7.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Glow Lifetech | CSE | Healthcare | Biotechnology & Medical Research | $10.19M | -3.1x | -0.18 | $0.06 | -7.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
BetterLife Pharma Inc | CSE | Healthcare | Biotechnology & Medical Research | $10.13M | -3.2x | 0.04 | $0.09 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
BetterLife Pharma Inc | CSE | Healthcare | Biotechnology & Medical Research | $10.13M | -3.2x | 0.04 | $0.09 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Telo Genomics | TSXV | Healthcare | Biotechnology & Medical Research | $10M | -3.4x | -0.14 | $0.10 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Quest PharmaTech | TSXV | Healthcare | Biotechnology & Medical Research | $8.46M | -2.4x | -0.04 | $0.05 | 66.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Revive Therapeutics | CSE | Healthcare | Biotechnology & Medical Research | $8.37M | -0.4x | 0.23 | $0.02 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Revive Therapeutics | CSE | Healthcare | Biotechnology & Medical Research | $8.37M | -0.4x | 0.23 | $0.02 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Medicure | TSXV | Healthcare | Biotechnology & Medical Research | $7.10M | -4.4x | 0.01 | $0.68 | -13.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Innovotech | TSXV | Healthcare | Biotechnology & Medical Research | $6.71M | -25.9x | 1.19 | $0.14 | -3.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Principal Tech | TSXV | Healthcare | Biotechnology & Medical Research | $6.20M | -0.23 | $0.17 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
Marvel Biosciences | TSXV | Healthcare | Biotechnology & Medical Research | $5.60M | -3.3x | -0.09 | $0.13 | -7.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Asep Medical Holdings | CSE | Healthcare | Biotechnology & Medical Research | $5.38M | -1.1x | -0.02 | $0.07 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Asep Medical Holdings | CBOE Canada | Healthcare | Biotechnology & Medical Research | $5.38M | -1.1x | -0.02 | $0.07 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
StageZero Life Sciences | Toronto | Healthcare | Biotechnology & Medical Research | $4.94M | -0.2x | $0.04 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | |||
XORTX Therapeutics | TSXV | Healthcare | Biotechnology & Medical Research | $4.85M | -0.9x | 0.18 | $1.28 | -1.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |